Business
Why the Genetic Signatures (ASX:GSS) share price is edging higher
The Genetic Signatures Ltd (ASX: GSS) share price is edging higher today. This comes after the company announced that it received CE-IVD registration for its 3base EasyScreen sexually transmitted infection (STI) Genital Pathogen Detection Kit.
CE-IVD refers to an approved CE Marking from the European Union for an in vitro diagnostic (IVD) device. This allows the product to be commercially sold within Europe.
What’s driving the Genetic Signatures share price higher
The Genetic Signatures share price is back positive territory as investors jump on the company’s latest news. Originally, the company’s shares were sliding lower on the back of overall weak market sentiment.
According to its release, Genetic Signatures advised its…
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News22 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo